Stay updated on Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.

Latest updates to the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRecruitment status now shows 'No longer looking for participants', indicating enrollment is closed. The update also adds help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header with Revision: v3.6.0, replacing the prior version.SummaryDifference0.2%

- Check20 days agoChange DetectedFooter now shows Revision: v3.5.5 instead of v3.5.4, indicating a page revision or update. This signals a minor update rather than substantive changes to the study data.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous v3.5.3, indicating a new release of the study page.SummaryDifference0.0%

- Check48 days agoChange DetectedThe Taiwan location in the study's locations list was updated from Taoyuan District to Taoyuan, Taiwan, 33305. This corrects the geographic designation used for that site in the trial record.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page’s revision identifier was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.